Showing results (1971-1980 of 2,096) with videos related to
Sort By:
Pageof 210
The Journal of Infection|June 7, 2015
Markers of endothelial cell activation and immune activation are increased in patients with severe leptospirosis and associated with disease severityMarco Goeijenbier, M Hussein Gasem, Joost C M Meijers, et al.The Journal of Biological Chemistry|January 15, 2004
Enzymatic characterization of the pancreatic islet-specific glucose-6-phosphatase-related protein (IGRP)Anthony J Petrolonis, Qing Yang, Peter J Tummino, et al.Patient Education and Counseling|April 22, 2026
Exploring patients' and caregivers' experience of therapeutic patient education in rare diseases: A qualitative studyRobin Bouillé, Soumaya Balbolia, Audrey Barbet, et al.Journal of Medicinal Chemistry|July 13, 2026
X-ray Crystallography-Guided Design and Synthesis of Cyclopentyl Heteroaryl Carboxylic Acid-Based Inhibitors of the SARS-CoV-2 Nsp3 Macrodomain (Mac1)Xinyu Wang, William T W Butler, James R Donald, et al.Journal of Cardiovascular Electrophysiology|July 2, 2019
Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic functionMatthew M Zipse, Wendy S Tzou, Joseph L Schuller, et al.BMC Research Notes|January 9, 2014
IL28B and IL10R -1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohortAlajos Pár, Gabriella Pár, István Tornai, et al.Cell|June 24, 2021
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrityTilak Kumar Gupta, Sven Klumpe, Karin Gries, et al.Molecular Cell|April 28, 2023
Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signalingEdoardo José Longarini, Helen Dauben, Carolina Locatelli, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Initial Clinical Experience with [177Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and DosimetryLisa Glantschnig, Johanna S Enke, Bradley W Schuller, et al.Nature Communications|February 24, 2026
Context-dependent translation inhibition as a cancer therapeutic modalityPaige D Diamond, Paul V Sauer, Mikael Holm, et al.Pageof 210